Literature DB >> 12719455

Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status.

J Wehkamp1, K Schmidt, K R Herrlinger, S Baxmann, S Behling, C Wohlschläger, A C Feller, E F Stange, K Fellermann.   

Abstract

BACKGROUND/AIMS: Recent reports have suggested that Helicobacter pylori infection induces the mucosal antibiotic peptide human beta defensin 2 (HBD-2). Therefore, the present study investigated mRNA and peptide expression of four different defensins in the upper gastrointestinal tract in patients with H pylori positive and negative chronic gastritis. MATERIALS/
METHODS: Biopsies from the oesophagus to the duodenum were taken during routine gastroscopy in 71 individuals. Total RNA was extracted and the reverse transcription polymerase chain reaction was performed with primers for human defensins 5 and 6 (HD-5/6) or HBD-1 and HBD-2. Paraffin wax embedded tissue from gastric resections was tested for HD-5, HBD-1, and HBD-2 by immunohistochemistry.
RESULTS: Helicobacter pylori colonisation was associated with an increased percentage of positive biopsies with respect to HBD-2 in the corpus (p < 0.05). Helicobacter pylori had no impact on the gastric expression of HD-5 and HBD-1, whereas HD-6 was increased in the fundus. The abundant expression of alpha defensins in the duodenum and beta defensins in the oesophagus served as a positive control in each individual. Immunohistochemical analysis confirmed the presence of the HD-5, HBD-1, and HBD-2 peptides in gastric resection specimens.
CONCLUSIONS: The recently described induction of HBD-2 upon H pylori infection was confirmed in a clinical setting of chronic gastritis. This phenomenon may be mediated by components of the pathogen itself or may occur secondary to immune events in chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719455      PMCID: PMC1769951          DOI: 10.1136/jcp.56.5.352

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  29 in total

Review 1.  Defensins and innate host defence of the gastrointestinal tract.

Authors:  C L Bevins; E Martin-Porter; T Ganz
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

2.  Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells.

Authors:  S Keates; Y S Hitti; M Upton; C P Kelly
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

3.  Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation.

Authors:  L Liu; L Wang; H P Jia; C Zhao; H H Heng; B C Schutte; P B McCray; T Ganz
Journal:  Gene       Date:  1998-11-19       Impact factor: 3.688

4.  Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells.

Authors:  C Zhao; I Wang; R I Lehrer
Journal:  FEBS Lett       Date:  1996-11-04       Impact factor: 4.124

5.  A peptide antibiotic from human skin.

Authors:  J Harder; J Bartels; E Christophers; J M Schröder
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

6.  Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis.

Authors:  S Fu; K S Ramanujam; A Wong; G T Fantry; C B Drachenberg; S P James; S J Meltzer; K T Wilson
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

7.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.

Authors:  E V Valore; C H Park; A J Quayle; K R Wiles; P B McCray; T Ganz
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

8.  Induction of human beta-defensin-2 mRNA expression by Helicobacter pylori in human gastric cell line MKN45 cells on cag pathogenicity island.

Authors:  A Wada; N Mori; K Oishi; H Hojo; Y Nakahara; Y Hamanaka; M Nagashima; I Sekine; K Ogushi; T Niidome; T Nagatake; J Moss; T Hirayama
Journal:  Biochem Biophys Res Commun       Date:  1999-10-05       Impact factor: 3.575

Review 9.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

Authors:  M F Dixon; R M Genta; J H Yardley; P Correa
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

10.  Enteric defensin expression in necrotizing enterocolitis.

Authors:  N H Salzman; R A Polin; M C Harris; E Ruchelli; A Hebra; S Zirin-Butler; A Jawad; E Martin Porter; C L Bevins
Journal:  Pediatr Res       Date:  1998-07       Impact factor: 3.756

View more
  21 in total

1.  Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects.

Authors:  Marco Antonio Moro-García; Rebeca Alonso-Arias; Maria Baltadjieva; Carlos Fernández Benítez; Manuel Amadeo Fernández Barrial; Enrique Díaz Ruisánchez; Ricardo Alonso Santos; Magdalena Alvarez Sánchez; Juan Saavedra Miján; Carlos López-Larrea
Journal:  Age (Dordr)       Date:  2012-05-30

2.  A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media.

Authors:  Glen McGillivary; William C Ray; Charles L Bevins; Robert S Munson; Lauren O Bakaletz
Journal:  Mol Immunol       Date:  2006-11-20       Impact factor: 4.407

3.  Natural antibiotic expression in celiac disease--correlation with villous atrophy and response to a gluten-free diet.

Authors:  Ali S Taha; Elena Faccenda; Wilson J Angerson; Margaret Balsitis; Rodney W Kelly
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 4.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

5.  Enhanced human beta-defensin-2 (hBD-2) expression by corticosteroids is independent of NF-kappaB in colonic epithelial cells (CaCo2).

Authors:  T Witthöft; C S Pilz; K Fellermann; M Nitschke; E F Stange; D Ludwig
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

6.  High concentrations of human beta-defensin 2 in gastric juice of patients with Helicobacter pylori infection.

Authors:  Hajime Isomoto; Hiroshi Mukae; Hiroshi Ishimoto; Yoshito Nishi; Chun-Yang Wen; Akihiro Wada; Ken Ohnita; Toshiya Hirayama; Masamitsu Nakazato; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

7.  Human defensin 5 expression in intestinal metaplasia of the upper gastrointestinal tract.

Authors:  B Shen; E M Porter; E Reynoso; C Shen; D Ghosh; J T Connor; J Drazba; H K Rho; T L Gramlich; R Li; A H Ormsby; M-S Sy; T Ganz; C L Bevins
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

8.  NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.

Authors:  Jan Wehkamp; Jürgen Harder; Kai Wehkamp; Birte Wehkamp-von Meissner; Miriam Schlee; Corinne Enders; Ulrich Sonnenborn; Sabine Nuding; Stig Bengmark; Klaus Fellermann; Jens Michael Schröder; Eduard F Stange
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Gastric transcription profile of Helicobacter pylori infection in the rhesus macaque.

Authors:  Jennifer L Huff; Lori M Hansen; Jay V Solnick
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Antimicrobial peptides in gastrointestinal inflammation.

Authors:  Simon Jäger; Eduard F Stange; Jan Wehkamp
Journal:  Int J Inflam       Date:  2010-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.